This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Apr;7(4):243-245.

doi: 10.1016/S2213-8587(19)30064-6. Epub 2019 Feb 22.

Definitions of intermediate hyperglycaemia and progression to type 2 diabetes

Jaakko Tuomilehto¹

Affiliations

PMID: 30803930
DOI: 10.1016/S2213-8587(19)30064-6

Comment

Definitions of intermediate hyperglycaemia and progression to type 2 diabetes

Jaakko Tuomilehto. Lancet Diabetes Endocrinol. 2019 Apr.

. 2019 Apr;7(4):243-245.

doi: 10.1016/S2213-8587(19)30064-6. Epub 2019 Feb 22.

Author

Jaakko Tuomilehto¹

Affiliation

¹ Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland. Electronic address: jaakko.tuomilehto@thl.fi.

PMID: 30803930
DOI: 10.1016/S2213-8587(19)30064-6

No abstract available

PubMed Disclaimer

Comment on

Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
Schmidt MI, Bracco PA, Yudkin JS, Bensenor IM, Griep RH, Barreto SM, Castilhos CD, Duncan BB. Schmidt MI, et al. Lancet Diabetes Endocrinol. 2019 Apr;7(4):267-277. doi: 10.1016/S2213-8587(19)30058-0. Epub 2019 Feb 22. Lancet Diabetes Endocrinol. 2019. PMID: 30803929

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information